BIO

Dr. Daniel Karlin, Greg Plante, Dr. Stephen Wicks, Dr. Zachary Beattie, and Dr. Mahesh Fuldeore

By Jonah Comstock June 8, 2018
Pharma companies are increasingly embracing the use of wearables and other connected devices to streamline and improve data collection in clinical trials. But for all the advantages these devices might have, there also challenges — especially when it comes to data standardization. This week at BIO 2018, Dr. Daniel Karlin, Pfizer’s head of clinical, informatics, regulatory strategy, digital...
By Jonah Comstock June 24, 2015
Participants in MIT's 2014 Hackathon with MGH and Samsung. MIT's Hacking Medicine program, which has organized medical hackathons since 2011, has launched a new spin-off: the Hacking Medicine Institute, a 501c3 nonprofit with a slightly different mission. The new organization will assess whether digital health products and services really work and, if they do, help them to prove their efficacy...
By Jonah Comstock June 18, 2015
Personalized medicine was a hot topic at the BIO conference in Philadelphia, but in a session on digital health and patient engagement, payer and provider panelists also talked about how, in order to really drive medication and treatment adherence, patient engagement also has to be personalized. "You have to understand what are they worried about, what are their fears, what are they trying to do...
By Jonah Comstock June 17, 2015
Dr. Eric Topol's newest book is called "The Patient Will See You Now." At BIO during his keynote talk, a whirlwind overview of the digital health space, Topol freely acknowledged that he wasn't the first person to riff on that phrase. "It takes 2.6 weeks to get an appointment with a primary care doctor on average. Since it’s hard to see a doctor is, what’s really interesting in contrast is that...
By Jonah Comstock June 17, 2015
Pfizer Head of Clinical Innovation Craig Lipset In 2011, Pfizer announced a novel clinical trial that would be fully remote, with every aspect of the trial being handled either online, over the phone, or by mail. But that trial was cancelled due to a failure to recruit enough participants, and a promised mulligan never emerged. Craig Lipset, Pfizer's Head of Clinical Innovation, said at the...
By Jonah Comstock June 16, 2015
Innovation in digital health won’t come in a gradual, incremental way, but rather through dramatic re-imaginings of care. That was the theme that ran through the morning conversation in the digital health track at the 2015 BIO International Convention, a pharma and life sciences-focused conference held in Philadelphia this week. “We’re in a disruptive time. We’re in a time of moonshots, when...

Editor's Pick